Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K081921
    Date Cleared
    2008-08-06

    (30 days)

    Product Code
    Regulation Number
    892.1550
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    GE VIVID E9 ULTRASOUND

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows: Fetal / Obstetrics, Abdominal (including renal and GYN), Pediatric, Small Organ (breast, testes, thyroid), Neonatal Cephalic, Adult Cephalic, Cardiac (adult and pediatric), Peripheral Vascular (PV), Musculo-skeletal Conventional, Urology (including prostate), Transesophageal, Transvaginal (TV), and Intraoperative (abdominal, thoracic, & vascular).

    Device Description

    The GE Vivid E9 Ultrasound is a full featured echocardiography imaging and analysis system. It consists of a mobile console with multiple electronic array transducers that provides digital acquisition, processing and display capability. The user interface includes a floating and variable height user control panel with specialized controls, high resolution LCD display and separate LCD touch panel. This modification offers improved performance and productivity for users in a smaller and lighter weight package.

    AI/ML Overview

    This document describes the Summary of Safety and Effectiveness for the GE Vivid E9 Ultrasound system, prepared in accordance with 21 CFR Part 807.92(c).

    Acceptance Criteria and Device Performance:

    The document primarily focuses on demonstrating substantial equivalence to a predicate device (GE Vivid 7 Diagnostic Ultrasound) rather than establishing specific quantitative acceptance criteria for device performance. The "acceptance criteria" are implied to be adherence to medical device safety standards and comparable performance to the predicate.

    The table below summarizes the claimed performance characteristics and indications for use, noting that these are "previously cleared by FDA" (P) or "new indication" (N) for specific transducers. The core acceptance criterion for the device itself is its safety and effective performance, which is stated to be consistent with traditional clinical practice and FDA guidelines.

    Acceptance Criteria (Implied)Reported Device Performance
    Conformance with applicable medical device safety standards.The device has been evaluated for acoustic output, biocompatibility, cleaning and disinfection effectiveness, electromagnetic compatibility, as well as thermal, electrical and mechanical safety, and has been found to conform with applicable medical device safety standards.
    Consistent with traditional clinical practice and FDA guidelinesIntended uses and other key features are consistent with traditional clinical practice, FDA guidelines, and established methods of patient examination. The design and development process of the manufacturer conforms with 21 CFR 820, ISO 9001:2000 and ISO 13485 quality systems. The device conforms to applicable medical device safety standards and compliance is verified through independent evaluation with ongoing factory surveillance. Diagnostic ultrasound has accumulated a long history of safe and effective performance.
    Substantial equivalence to predicate device (GE Vivid 7)The GE Vivid E9 is of a comparable type and substantially equivalent to the current GE Vivid 7 with overall enhanced performance in a smaller and more compact package. It has the same overall characteristics, key safety and effectiveness features, physical design, general overall construction, and materials, and has the same intended uses and operating modes as the predicate device.
    Indications for Use (Per Transducer)(Each "P" or "N" in the following tables indicates claimed performance for that mode/application)
    GE Vivid E9 Ultrasound System (Overall)Clinical applications: Ophthalmic, Fetal/Obstetrics, Abdominal (including renal and GYN), Pediatric, Small Organ (breast, testes, thyroid), Neonatal Cephalic, Adult Cephalic, Cardiac (adult and pediatric), Peripheral Vascular, Musculo-skeletal Conventional, Musculo-skeletal Superficial, Urology (including prostate), Transesophageal, Transvaginal, Intraoperative (abdominal, thoracic, & vascular). All listed modes (B, M, PW Doppler, CW Doppler, Color Doppler, Color M Doppler, Power Doppler, Combined Modes, Harmonic Imaging, Coded Pulse, RT3D Mode) are claimed as 'P' for most applications, except for harmonic imaging, which is not universally 'P' across all applications. Notably, Intraoperative is 'N' for Coded Pulse.
    GE Vivid E9 with 4C-D TransducerFetal/Obstetrics (P), Abdominal (P), Pediatric (P), Peripheral Vascular (P), Urology (P). All listed modes except CW Doppler are 'P' for these applications. Harmonic Imaging is 'P' for all except Urology, which is blank for Harmonic.
    GE Vivid E9 with 9L-D TransducerPediatric (P), Small Organ (P), Peripheral Vascular (P), Musculo-skeletal Conventional (P). All listed modes except CW Doppler are 'P' for these applications.
    GE Vivid E9 with 11L-D TransducerPediatric (N), Small Organ (N), Peripheral Vascular (N), Musculo-skeletal Conventional (N), Intraoperative (N). All listed modes including CW Doppler are 'N' for these applications.
    GE Vivid E9 with M4S-D TransducerFetal/Obstetrics (P), Abdominal (P), Pediatric (P), Adult Cephalic (P), Cardiac (P), Other[Urology/Prostate] (P). All listed modes including CW Doppler are 'P' for these applications.
    GE Vivid E9 with M5S-D TransducerFetal/Obstetrics (N), Abdominal (N), Pediatric (N), Adult Cephalic (N), Cardiac (N), Other[Urology/Prostate] (N). All listed modes including CW Doppler are 'N' for these applications.
    GE Vivid E9 with 6S-D TransducerFetal/Obstetrics (N), Abdominal (N), Pediatric (N), Neonatal Cephalic (N), Cardiac (N). All listed modes including CW Doppler are 'N' for these applications.
    GE Vivid E9 with 3V-D TransducerFetal/Obstetrics (P), Abdominal (P), Pediatric (P), Adult Cephalic (P), Cardiac (P), Other [Urology/Prostate] (P). All listed modes including CW Doppler, RT3D Mode, Combined Modes, Harmonic, and Coded Pulse are 'P' for these applications.
    GE Vivid E9 with E8C-D TransducerFetal/Obstetrics (P), Abdominal (P), Other[Urology/Prostate] (P), Transrectal (P), Transvaginal (P). All listed modes except CW Doppler and Harmonic Imaging are 'P' for these applications.
    GE Vivid E9 with 6T or 6Tc TransducerCardiac (P), Transesophageal (P). All listed modes including CW Doppler are 'P' for these applications.
    GE Vivid E9 with 9T TransducerCardiac (P), Transesophageal (P). All listed modes including CW Doppler are 'P' for these applications.
    GE Vivid E9 with P2D TransducerCardiac (P) and Peripheral Vascular (P) for PW Doppler and CW Doppler modes only. Other modes are not specified.
    GE Vivid E9 with P6D TransducerCardiac (P) and Peripheral Vascular (P) for PW Doppler and CW Doppler modes only. Other modes are not specified.

    Study Details:

    A formal clinical study to prove the device meets acceptance criteria was not required or performed for this 510(k) submission.

    • 1. A table of acceptance criteria and the reported device performance: See table above.

    • 2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective):

      • No clinical test set was used, as clinical tests were stated as "None required."
      • Therefore, no sample size, data provenance, or retrospective/prospective nature of the data is reported.
    • 3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience):

      • Not applicable, as no clinical test set was utilized and no ground truth was formally established for direct comparison of the new device's performance against clinical outcomes. The equivalence relies on the established safety and efficacy of diagnostic ultrasound and its predicate.
    • 4. Adjudication method (e.g. 2+1, 3+1, none) for the test set:

      • Not applicable, as no clinical test set was utilized.
    • 5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

      • No MRMC comparative effectiveness study was done. This submission is for an ultrasound imaging system, not an AI-powered diagnostic aid. The device is a diagnostic ultrasound system, and the submission emphasizes its substantial equivalence to a predicate device and adherence to safety standards, not an improvement in human reader performance through AI assistance.
    • 6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done:

      • Not applicable. This device is a diagnostic ultrasound system that requires human operation, not a standalone AI algorithm.
    • 7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.):

      • Not applicable. No new ground truth for performance evaluation was established for this submission, as clinical tests were not required. The "ground truth" for the device's acceptable safety and effectiveness is implied through its adherence to established medical device safety standards and the long history of safe and effective performance of diagnostic ultrasound as a modality.
    • 8. The sample size for the training set:

      • Not applicable. This device is a hardware/software system, not a machine learning model requiring a training set in the typical sense.
    • 9. How the ground truth for the training set was established:

      • Not applicable, as no training set for a machine learning model was used.
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1